The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence
{{output}}
Introduction: Acute myeloid leukemia (AML) is an aggressive hematologic cancer that accounts for approximately one third of all newly diagnosed leukemias annually in the United States (US), and is associated with high mortality a... ...
